CHOP Protein

CHOP Protein - Comprehensive Scientific Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CHOP Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CHOP</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CHOP</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=CHOP" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">497 edges</a></td>
</tr>
</table>

Overview

CHOP Protein - Comprehensive Scientific Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CHOP Protein</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CHOP</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CHOP</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=CHOP" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/ali" style="color:#ef9a9a">ALI</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">497 edges</a></td>
</tr>
</table>

Overview

CHOP (C/EBP Homologous Protein), also known as DDIT3 (DNA Damage-Inducible Transcript 3), is a leucine zipper transcription factor that functions as a critical regulator of cellular stress responses, particularly during endoplasmic reticulum (ER) stress and the unfolded protein response (UPR). Under normal physiological conditions, CHOP expression is minimal, but it is rapidly induced when cells encounter proteotoxic stressors such as misfolded proteins, calcium depletion, or oxidative stress. As a member of the CCAAT/Enhancer Binding Protein (C/EBP) family, CHOP heterodimerizes with other bZIP proteins and modulates the transcription of genes involved in apoptosis, autophagy, and metabolic adaptation.

Key Mechanisms and Functions

• ER Stress-Induced Transcription Factor Activation: CHOP is phosphorylated and activated through three major UPR pathways initiated by ER-resident kinases (IRE1α, PERK, and ATF6) in response to ER protein overload. Once activated, CHOP translocates to the nucleus where it binds to C/EBP-ATF composite sites (CHOP-binding elements) in promoter regions of target genes. This activation is time-dependent; prolonged CHOP expression typically indicates the transition from adaptive stress response to pro-apoptotic signaling (PMID:15964971, PMID:23454573).
• Pro-Apoptotic Gene Regulation: CHOP functions as a central hub in determining cell fate during sustained ER stress by upregulating pro-apoptotic genes including BIM (BCL2L11), PUMA (BBC3), and DR5 (TNFRSF10B), while simultaneously suppressing anti-apoptotic genes such as BCL2 and MCL1. This regulatory switch ensures that irreversibly damaged cells undergo programmed cell death rather than persisting with compromised protein homeostasis. The CHOP-mediated apoptotic program is particularly critical in neurons, where protein misfolding can propagate through neural circuits and compromise network function (PMID:17525332).
• Metabolic Reprogramming and Autophagy Modulation: Beyond its pro-death functions, CHOP regulates metabolic genes involved in amino acid synthesis and lipid metabolism, facilitating metabolic adaptation during stress. CHOP also promotes autophagy through induction of ATG genes, representing an initial attempt at cellular salvage before apoptosis is triggered. This dual functionality allows cells to distinguish between recoverable stress and irreversible proteotoxic burden (PMID:26033813).
• Redox Homeostasis Disruption: CHOP activation leads to decreased expression of antioxidant defense genes, including those encoding glutathione S-transferases and thioredoxins, thereby increasing reactive oxygen species (ROS) accumulation. This ROS-mediated damage further propagates ER stress through positive feedback loops and amplifies pro-apoptotic signaling. In neurons, ROS accumulation is particularly detrimental due to high metabolic demands and limited regenerative capacity (PMID:17934471).
• Neuroinflammatory Signal Integration: Recent evidence indicates that CHOP interacts with inflammatory pathways, particularly through NF-κB signaling, to coordinate innate immune responses during neurodegeneration. CHOP can modulate the expression of pro-inflammatory cytokines (TNF-α, IL-6) and chemokines, linking cellular stress responses to systemic neuroinflammation (PMID:27687943).

Relevance to Neurodegeneration and Disease

CHOP represents a critical convergence point in multiple neurodegenerative disease pathways. In Alzheimer's disease (AD), amyloid-beta (Aβ) oligomers and tau tangles trigger chronic ER stress, leading to sustained CHOP activation in vulnerable neurons. Studies have demonstrated elevated CHOP expression in post-mortem AD brain tissue, particularly in regions exhibiting tau pathology and neuronal loss (PMID:19460865). The accumulation of CHOP-induced pro-apoptotic signals contributes directly to the neuronal death observed in AD, with CHOP knockout or knockdown showing neuroprotective effects in animal models of AD-related pathology.

In Parkinson's disease (PD), α-synuclein misfolding and aggregation generates proteotoxic stress that activates the CHOP-mediated UPR in dopaminergic neurons. The selective vulnerability of substantia nigra neurons in PD correlates with their high energetic demands and dependence on efficient protein quality control systems. CHOP activation exacerbates this vulnerability by promoting apoptosis and suppressing protective autophagy responses, creating a pathological cycle. Similarly, in amyotrophic lateral sclerosis (ALS), both SOD1 mutations and TDP-43 pathology trigger ER stress and CHOP-dependent neuronal death. CHOP inhibition has emerged as a potential therapeutic strategy in ALS models, with CHOP-deficient mice showing delayed motor neuron degeneration (PMID:19525936).

Prion diseases represent particularly stark examples of CHOP's role in neurodegeneration. Prion protein (PrP) misfolding generates severe ER stress and robust CHOP induction throughout affected brain regions. The intensity of CHOP activation correlates temporally with disease progression, and genetic deletion of CHOP extends survival in prion-infected animals, suggesting that the pro-apoptotic CHOP response, while initially protective against prion propagation, ultimately contributes to neuronal demise (PMID:17540829). Additionally, in polyglutamine diseases such as Huntington's disease, mutant huntingtin proteins with expanded polyglutamine repeats trigger ER stress and sustained CHOP activation, with accumulating evidence supporting a causal link between CHOP signaling and disease pathogenesis.

Current Research Directions

• Selective CHOP Inhibition Strategies: The challenge in CHOP-directed therapeutics lies in preserving its adaptive stress-response functions while blocking its pro-apoptotic outputs. Emerging approaches include cell-type specific CHOP inhibition using viral vectors or antisense oligonucleotides, selective targeting of CHOP-ATF4 heterodimers over CHOP-C/EBPβ complexes, and pharmacological agents that modulate CHOP's DNA-binding domain specificity. Recent high-throughput screening efforts have identified novel small-molecule CHOP antagonists with blood-brain barrier penetration suitable for neurodegenerative disease applications (PMID:28119440).
• CHOP Interactions with Autophagy and Mitophagy Pathways: Advanced research is delineating how CHOP-regulated autophagy intersects with mitochondrial quality control mechanisms crucial for neuronal survival. Understanding CHOP's role in selective autophagy of damaged organelles, particularly mitophagy during mitochondrial dysfunction, may reveal opportunities to enhance neuroprotective autophagy while suppressing pro-death CHOP functions. This direction is particularly relevant for diseases featuring mitochondrial pathology, including PD and AD.
• Biomarker Development and Longitudinal Monitoring: CHOP phosphorylation status and its target gene expression signatures are being developed as biomarkers for ER stress burden in neurodegenerative diseases. Emerging technologies including cerebrospinal fluid biomarkers, PET imaging agents targeting CHOP-induced protein expression, and functional neuroimaging correlates of CHOP activation may enable earlier disease detection and therapeutic response monitoring in clinical trials. Such biomarkers could facilitate patient stratification for CHOP-directed therapies and provide objective measures of target engagement.

Key Regulatory Mechanisms and Protein Interactions

CHOP's activity is tightly regulated through multiple post-translational modifications and protein-protein interactions. Phosphorylation by PERK at serine 51 represents the primary mechanism of CHOP stabilization and nuclear accumulation (PMID:17139291). Additionally, CHOP undergoes ubiquitin-mediated proteasomal degradation through E3 ligase complexes including SCF^(Fbw7), which recognize CHOP only when it is phosphorylated, creating a temporal limitation on CHOP signaling duration (PMID:21873635). Sumoylation of CHOP modulates its transcriptional activity and subcellular localization, while acetylation by histone acetyltransferases

Pathway Diagram

Pathway Diagram

The following diagram shows the key molecular relationships involving CHOP Protein discovered through SciDEX knowledge graph analysis: